Statement of Ownership (sc 13g)
February 13 2020 - 11:17AM
Edgar (US Regulatory)
|
UNITED
STATES
|
|
|
SECURITIES AND
EXCHANGE COMMISSION
|
|
|
Washington, D.C. 20549
|
|
SCHEDULE
13G
Under the Securities Exchange Act of
1934
Bionik Laboratories Corp
(Name of Issuer)
Common stock, par value $0.001 per Share
(Title of Class of Securities)
09074A208
(CUSIP Number)
28 March 2019
(Date of Event Which Requires Filing
of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
x
|
Rule 13d-1(b)
|
o
|
Rule 13d-1(c)
|
o
|
Rule 13d-1(d)
|
|
*
|
The remainder of this cover page shall be filled out for a reporting person's initial
filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
|
The information required in
the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other
provisions of the Act (however, see the Notes).
1
|
Name of Reporting Person:
Lombard International Assurance S.A.
|
2
|
Check the Appropriate Box if a Member of a Group (see instructions)
(a) o (b) x
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization
Luxembourg
|
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With :
|
5
|
Sole Voting Power
131,9101
|
6
|
Shared Voting Power
None
|
7
|
Sole Dispositive Power
131,9101
|
8
|
Shared Dispositive Power
None
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
131,9101
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares o
|
11
|
Percent of Class Represented by Amount in Row (9)
2.65%
|
12
|
Type of Reporting Person
FI
|
1 Includes 119,104 shares of Company common
stock and warrants to purchase 12,806 shares of Company common stock.
Item 1(a).
|
Name of Issuer.
|
Bionik Laboratories Corp (the “Issuer”).
|
|
|
Item 1(b).
|
Address of Issuer’s Principal
Executive Offices.
|
|
|
The principal executive offices of the Issuer are located at 483 Bay Street, N105, Toronto, Ontario M5G2C9.
|
|
Item 2(a).
|
Names of Persons Filing.
|
This Schedule 13G is filed on behalf of Lombard International Assurance S.A.
|
|
|
Item 2(b).
|
Address or Principal
Business Office or, if none, Residence.
|
Lombard International Assurance S.A.
4, rue Lou Hemmer
L-1748 Luxembourg
Luxembourg
|
|
|
Item 2(c).
|
Citizenship.
|
|
|
Luxembourg
|
|
|
Item 2(d).
|
Title of Class of Securities.
|
|
|
Common Stock and Warrants
|
|
|
Item 2(e).
|
CUSIP Number.
|
|
|
09074A208
|
Item 3.
|
If this statement is filed pursuant
to Rule 13d-1(b), or 13d-3(b) or (c), check whether the person filing is a:
|
|
|
|
|
¨
|
Not Applicable
|
|
(a)
|
¨
|
Broker or dealer registered under section 15 of the Act;
|
|
(b)
|
¨
|
Bank as defined in section 3(a)(6) of the Act;
|
|
(c)
|
¨
|
Insurance company as defined in section 3(a)(19) of the Act;
|
|
(d)
|
¨
|
Investment company registered under section 8 of the Investment Company Act of 1940;
|
|
(e)
|
¨
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
|
|
(g)
|
¨
|
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
|
|
(h)
|
¨
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
|
|
(j)
|
x
|
A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
|
|
(k)
|
¨
|
Group, in accordance with Rule 13d-1(b)(1)(ii)(K).
|
(a)
Amount beneficially owned:
131,910 (Includes 119,104 shares
of Company common stock and warrants to purchase 12,806 shares of Company common stock)
(b)
Percent of class:
2.65%
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote
131,9102
(ii)
Shared power to vote or to direct the vote
None
(iii)
Sole power to dispose or to direct the vote
131,9102
(iv)
Shared power to dispose or to direct the disposition of
None
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x
|
|
Note:
Beneficial ownership of more than five percent of the class
of securities ceased due to increase of outstanding shares of the company.
|
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
|
|
Not applicable.
|
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
|
|
|
Not applicable.
|
|
Item 8.
|
Identification and Classification of Members of the Group.
|
|
|
Not applicable
|
|
Item 9.
|
Notice of Dissolution of Group.
|
|
|
Not applicable.
|
Item 10.
|
Certifications.
|
|
|
Not applicable.
|
2 Includes 119,104 shares of Company common
stock and warrants to purchase 12,806 shares of Company common stock
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: 12 February 2020
|
Lombard International Assurance S.A.
|
|
|
|
|
Bionik Laboratories (CE) (USOTC:BNKL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bionik Laboratories (CE) (USOTC:BNKL)
Historical Stock Chart
From Jul 2023 to Jul 2024